Li Chia-Wei, Dinh Gia Khanh, Chen J Don
Department of Pharmacology,University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Piscataway, New Jersey 08854-5635, USA.
Mol Pharmacol. 2009 Feb;75(2):363-73. doi: 10.1124/mol.108.047845. Epub 2008 Oct 31.
The silencing mediator for retinoid and thyroid hormone receptors (SMRT) serves as a platform for transcriptional repression elicited by several steroid/nuclear receptors and transcription factors. SMRT exists in two major splicing isoforms, alpha and tau, with SMRTalpha containing only an extra 46-amino acid sequence inserted immediately downstream from the C-terminal corepressor motif. Little is known about potential functional differences between these two isoforms. Here we show that the pregnane X receptor (PXR) interacts more strongly with SMRTalpha than with SMRTtau both in vitro and in vivo. It is interesting that the PXR-SMRTalpha interaction is also resistant to PXR ligand-induced dissociation, in contrast to the PXR-SMRTtau interaction. SMRTalpha consistently inhibits PXR activity more efficiently than does SMRTtau in transfection assays, although they possess comparable intrinsic repression activity and association with histone deacetylase. We further show that the mechanism for the enhanced PXR-SMRTalpha interaction involves both the 46-amino acid insert and the C-terminal corepressor motif. In particular, the first five amino acids of the SMRTalpha insert are essential and sufficient for the enhanced binding of SMRTalpha to PXR. Furthermore, we demonstrate that Tyr2354 and Asp2355 residues of the SMRTalpha insert are most critical for the enhanced interaction. In addition, expression data show that SMRTalpha is more abundantly expressed in most human tissues and cancer cell lines, and together these data suggest that SMRTalpha may play a more important role than SMRTtau in the negative regulation of PXR.
类视黄醇和甲状腺激素受体沉默介质(SMRT)作为由多种类固醇/核受体和转录因子引发的转录抑制平台。SMRT存在两种主要的剪接异构体,α和τ,其中SMRTα仅包含一个额外的46个氨基酸序列,该序列紧接在C末端共抑制基序下游插入。关于这两种异构体之间潜在的功能差异知之甚少。在这里,我们表明,孕烷X受体(PXR)在体外和体内与SMRTα的相互作用比与SMRTτ的相互作用更强。有趣的是,与PXR-SMRTτ相互作用相反,PXR-SMRTα相互作用也对PXR配体诱导的解离具有抗性。在转染实验中,SMRTα始终比SMRTτ更有效地抑制PXR活性,尽管它们具有相当的内在抑制活性并与组蛋白脱乙酰酶结合。我们进一步表明,增强的PXR-SMRTα相互作用的机制涉及46个氨基酸的插入序列和C末端共抑制基序。特别是,SMRTα插入序列的前五个氨基酸对于增强SMRTα与PXR的结合是必不可少且足够的。此外,我们证明SMRTα插入序列的Tyr2354和Asp2355残基对于增强相互作用最为关键。此外,表达数据表明,SMRTα在大多数人类组织和癌细胞系中表达更为丰富,这些数据共同表明,SMRTα在PXR的负调控中可能比SMRTτ发挥更重要的作用。